VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 183 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $1,106 | +6.7% | 262 | +9.2% | 0.00% | – |
Q3 2023 | $1,037 | -9.6% | 240 | +37.9% | 0.00% | – |
Q2 2023 | $1,147 | -1.8% | 174 | 0.0% | 0.00% | – |
Q1 2023 | $1,168 | -81.1% | 174 | -79.2% | 0.00% | -100.0% |
Q4 2022 | $6,171 | -31.4% | 835 | -3.1% | 0.00% | -50.0% |
Q3 2022 | $9,000 | 0.0% | 862 | +0.6% | 0.00% | +33.3% |
Q2 2022 | $9,000 | +12.5% | 857 | +14.6% | 0.00% | 0.0% |
Q1 2022 | $8,000 | -33.3% | 748 | -4.7% | 0.00% | -25.0% |
Q4 2021 | $12,000 | -7.7% | 785 | +4.5% | 0.00% | -20.0% |
Q3 2021 | $13,000 | -27.8% | 751 | -10.8% | 0.01% | -28.6% |
Q2 2021 | $18,000 | 0.0% | 842 | -30.3% | 0.01% | 0.0% |
Q1 2021 | $18,000 | +38.5% | 1,208 | +13.9% | 0.01% | +40.0% |
Q4 2020 | $13,000 | +30.0% | 1,061 | +0.7% | 0.01% | +25.0% |
Q3 2020 | $10,000 | +25.0% | 1,054 | +34.4% | 0.00% | 0.0% |
Q2 2020 | $8,000 | -11.1% | 784 | -13.5% | 0.00% | -20.0% |
Q1 2020 | $9,000 | – | 906 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |